Search Results

You are looking at 1 - 2 of 2 items for :

  • neuroendocrine neoplasms x
  • Top-cited articles of 2023 x
  • Refine by access: All content x
Clear All
Andreas Venizelos K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway
Department of Oncology, Haukeland University Hospital, Bergen, Norway

Search for other papers by Andreas Venizelos in
Google Scholar
PubMed
Close
,
Hege Elvebakken Department of Oncology, Ålesund Hospital, Møre og Romsdal Hospital Trust, Ålesund, Norway
Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway

Search for other papers by Hege Elvebakken in
Google Scholar
PubMed
Close
,
Aurel Perren Institute of Pathology, University of Bern, Bern, Switzerland

Search for other papers by Aurel Perren in
Google Scholar
PubMed
Close
,
Oleksii Nikolaienko K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway
Department of Oncology, Haukeland University Hospital, Bergen, Norway

Search for other papers by Oleksii Nikolaienko in
Google Scholar
PubMed
Close
,
Wei Deng K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway
Department of Oncology, Haukeland University Hospital, Bergen, Norway

Search for other papers by Wei Deng in
Google Scholar
PubMed
Close
,
Inger Marie B Lothe Department of Pathology, Oslo University Hospital, Oslo, Norway

Search for other papers by Inger Marie B Lothe in
Google Scholar
PubMed
Close
,
Anne Couvelard Department of Pathology, Université de Paris, Bichat Hospital, AP-HP, Paris, France

Search for other papers by Anne Couvelard in
Google Scholar
PubMed
Close
,
Geir Olav Hjortland Department of Oncology, Oslo University Hospital, Oslo, Norway

Search for other papers by Geir Olav Hjortland in
Google Scholar
PubMed
Close
,
Anna Sundlöv Departmentt of Oncology, Skåne University Hospital, Lund, Sweden
Department of Medical Radiation Physics, Lund University, Lund, Sweden

Search for other papers by Anna Sundlöv in
Google Scholar
PubMed
Close
,
Johanna Svensson Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden

Search for other papers by Johanna Svensson in
Google Scholar
PubMed
Close
,
Harrish Garresori Department of Oncology, Stavanger University Hospital, Stavanger, Norway

Search for other papers by Harrish Garresori in
Google Scholar
PubMed
Close
,
Christian Kersten Department of Research, Hospital of Southern Norway, Kristiansand, Norway

Search for other papers by Christian Kersten in
Google Scholar
PubMed
Close
,
Eva Hofsli Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway
Department of Oncology, St.Olavs Hospital, Trondheim, Norway

Search for other papers by Eva Hofsli in
Google Scholar
PubMed
Close
,
Sönke Detlefsen Department of Pathology, Odense University Hospital, Odense, Denmark
Department of Clinical Medicine, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark

Search for other papers by Sönke Detlefsen in
Google Scholar
PubMed
Close
,
Merete Krogh Department of Oncology, Odense University Hospital, Odense, Denmark

Search for other papers by Merete Krogh in
Google Scholar
PubMed
Close
,
Halfdan Sorbye Department of Oncology, Haukeland University Hospital, Bergen, Norway
Department of Clinical Science, University of Bergen, Bergen, Norway

Search for other papers by Halfdan Sorbye in
Google Scholar
PubMed
Close
, and
Stian Knappskog K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway
Department of Oncology, Haukeland University Hospital, Bergen, Norway

Search for other papers by Stian Knappskog in
Google Scholar
PubMed
Close

Introduction High-grade (HG) gastroenteropancreatic (GEP) neuroendocrine neoplasms (NEN) are defined by the presence of neuroendocrine phenotype and a high proliferation rate (Ki-67 > 20%). The HG NEN entity consists of well

Open access
James C Yao University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Search for other papers by James C Yao in
Google Scholar
PubMed
Close
,
Jonathan Strosberg Department of GI Oncology, Moffitt Cancer Center, Tampa, Florida, USA

Search for other papers by Jonathan Strosberg in
Google Scholar
PubMed
Close
,
Nicola Fazio European Institute of Oncology, IEO, IRCCS, Milan, Italy

Search for other papers by Nicola Fazio in
Google Scholar
PubMed
Close
,
Marianne E Pavel Department of Medicine 1, Friedrich Alexander University Erlangen-Nuremberg, Erlangen, Germany

Search for other papers by Marianne E Pavel in
Google Scholar
PubMed
Close
,
Emily Bergsland UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA

Search for other papers by Emily Bergsland in
Google Scholar
PubMed
Close
,
Philippe Ruszniewski Hôpital Beaujon, University of Paris, Paris, France

Search for other papers by Philippe Ruszniewski in
Google Scholar
PubMed
Close
,
Daniel M Halperin University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Search for other papers by Daniel M Halperin in
Google Scholar
PubMed
Close
,
Daneng Li City of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte, California, USA

Search for other papers by Daneng Li in
Google Scholar
PubMed
Close
,
Salvatore Tafuto Sarcomas and Rare Tumours Unit, Istituto Nazionale Tumori, IRCCS Fondazione G. Pascale, Naples, Italy

Search for other papers by Salvatore Tafuto in
Google Scholar
PubMed
Close
,
Nitya Raj Memorial Sloan Kettering Cancer Center, New York, New York, USA

Search for other papers by Nitya Raj in
Google Scholar
PubMed
Close
,
Davide Campana Department of Clinical Medicine, Sant’Orsola-Malpighi Hospital, University of Bologna, ENETS Center of Excellence, Bologna, Italy

Search for other papers by Davide Campana in
Google Scholar
PubMed
Close
,
Susumu Hijioka National Cancer Center Japan Tsukiji Campus, Department of Hepatobiliary and Pancreatic Oncology, Tokyo, Japan

Search for other papers by Susumu Hijioka in
Google Scholar
PubMed
Close
,
Markus Raderer Clinical Division of Oncology, Medical University of Vienna, Vienna, Austria

Search for other papers by Markus Raderer in
Google Scholar
PubMed
Close
,
Rosine Guimbaud CHU de Toulouse, Toulouse, France

Search for other papers by Rosine Guimbaud in
Google Scholar
PubMed
Close
,
Pablo Gajate Hospital Universitário Ramón y Cajal, Clinical Oncology Department, Madrid, Spain

Search for other papers by Pablo Gajate in
Google Scholar
PubMed
Close
,
Sara Pusceddu Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

Search for other papers by Sara Pusceddu in
Google Scholar
PubMed
Close
,
Albert Reising Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA

Search for other papers by Albert Reising in
Google Scholar
PubMed
Close
,
Evgeny Degtyarev Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA

Search for other papers by Evgeny Degtyarev in
Google Scholar
PubMed
Close
,
Mark Shilkrut Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA

Search for other papers by Mark Shilkrut in
Google Scholar
PubMed
Close
,
Simantini Eddy Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA

Search for other papers by Simantini Eddy in
Google Scholar
PubMed
Close
, and
Simron Singh Sunnybrook Health Sciences Centre, Toronto, Canada

Search for other papers by Simron Singh in
Google Scholar
PubMed
Close

years ( Yao et al. 2008 ). Neuroendocrine neoplasms (NENs) are comprised of well-differentiated NETs and poorly differentiated neuroendocrine carcinomas (NECs). The World Health Organization classification reported four categories, based on tumor

Restricted access